These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18683479)

  • 1. Vasopressin analogues in the treatment of hepatorenal syndrome and gastrointestinal haemorrhage.
    Döhler KD; Meyer M
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):335-50. PubMed ID: 18683479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vasoconstrictive Therapies for Bleeding Esophageal Varices and their Mechanisms of Action].
    Döhler KD; Walker S; Mentz P; Forssmann K; Staritz M
    Z Gastroenterol; 2003 Oct; 41(10):1001-16. PubMed ID: 14562199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terlipressin improves pulmonary pressures in cirrhotic patients with pulmonary hypertension and variceal bleeding or hepatorenal syndrome.
    Kalambokis GN; Pappas K; Tsianos EV
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):434-7. PubMed ID: 22893473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
    Saner FH; Canbay A; Gerken G; Broelsch CE
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):207-17. PubMed ID: 19072411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A; Borup T; Møller S; Bendtsen F
    Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of the complications of portal hypertension: variceal bleeding and ascites.
    Dib N; Oberti F; Calès P
    CMAJ; 2006 May; 174(10):1433-43. PubMed ID: 16682712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoconstrictor therapy for hepatorenal syndrome in liver cirrhosis.
    Schmidt LE; Ring-Larsen H
    Curr Pharm Des; 2006; 12(35):4637-47. PubMed ID: 17168767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists.
    Magan AA; Khalil AA; Ahmed MH
    World J Gastroenterol; 2010 Nov; 16(41):5139-47. PubMed ID: 21049548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terlipressin in hepatorenal syndrome: Evidence for present indications.
    Rajekar H; Chawla Y
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.
    Moreau R; Lebrec D
    Hepatology; 2006 Mar; 43(3):385-94. PubMed ID: 16496352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
    Testro AG; Angus PW
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1707-9. PubMed ID: 20136956
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoconstrictors in hepatorenal syndrome - A critical review.
    Mattos ÂZ; Schacher FC; Mattos AA
    Ann Hepatol; 2019; 18(2):287-290. PubMed ID: 31023616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of terlipressin in hepatorenal syndrome].
    Forcellini S; Fabbian F
    G Ital Nefrol; 2010; 27(5):469-76. PubMed ID: 20922678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terlipressin in the management of liver disease.
    Scheinberg AR; Martin P; Turkeltaub JA
    Expert Opin Pharmacother; 2023; 24(15):1665-1671. PubMed ID: 37535437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
    Kim HR; Lee YS; Yim HJ; Lee HJ; Ryu JY; Lee HJ; Yoon EL; Lee SJ; Hyun JJ; Jung SW; Koo JS; Choung RS; Lee SW; Choi JH
    Clin Mol Hepatol; 2013 Dec; 19(4):417-20. PubMed ID: 24459647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terlipressin: an asset for hepatologists!
    Sarin SK; Sharma P
    Hepatology; 2011 Aug; 54(2):724-8. PubMed ID: 21735463
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2.
    Alessandria C; Venon WD; Marzano A; Barletti C; Fadda M; Rizzetto M
    Eur J Gastroenterol Hepatol; 2002 Dec; 14(12):1363-8. PubMed ID: 12468959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.
    Uriz J; Ginès P; Cárdenas A; Sort P; Jiménez W; Salmerón JM; Bataller R; Mas A; Navasa M; Arroyo V; Rodés J
    J Hepatol; 2000 Jul; 33(1):43-8. PubMed ID: 10905585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation.
    Ganne-Carrié N; Hadengue A; Mathurin P; Durand F; Erlinger S; Benhamou JP
    Dig Dis Sci; 1996 Jun; 41(6):1054-6. PubMed ID: 8654133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.